Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q3 2025 Earnings

13AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.19

-0.98

-0.77

-0.56

Details

Expected EPS

-0.796

Actual EPS

-1.09

Surprise EPS

-0.29

Surprise Percent

+36.93%

Description

SAB Biotherapeutics (SABS) has reported earnings of -1.09 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.